Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuadrise Regulatory News (QED)

Share Price Information for Quadrise (QED)

Share Price is delayed by 15 minutes
Get Live Data
1.995    -0.215 (-9.73%)
Bid:
1.905
Ask:
2.19
Spread: 0.285 (14.961%)
Market Cap: £40.02m
QED Live PriceLast checked at - London Stock Exchange

Intraday Quadrise Share Chart

Disposal

17 Nov 2011 07:00

RNS Number : 2539S
Quintain Estates & Development PLC
17 November 2011
 



 

17 November 2011

Quintain Estates and Development plc

("Quintain" / "Company" / "Group")

 

Quintain achieves further progress with sales programme

£70m released from Wembley in the current financial year

 

Quintain announces that contracts have been exchanged regarding the sale of the Plaza Hotel, Wembley, to Sojourn Hotel Group. The sale price of £15m includes a payment of £1.75m, deferred for a year after completion, and will deliver a profit against book cost of £3.5m. The proceeds from the transaction, which will complete in June 2012, will be used to reduce forecast gearing levels.

 

The original Wembley planning consent, secured in 2004, assumed the redevelopment of the hotel into residential accommodation, which is reflected in the expected September valuation of the Plaza at £16m. However, in response to changing markets, Quintain's development strategy for the next two years is to focus on and complete the core leisure and entertainment elements of the scheme, comprising the new 4 star Hilton Hotel and the 350,000 sq ft London Designer Outlet. The Hilton will open before the Olympics next summer and the London Designer Outlet is on schedule to open in October 2013. Thereafter, activity will focus on residential elements of the development, including the 1.7m sq ft North West Lands surrounding Brent's new Civic Centre. The residential consent originally attributed to the Plaza site will be reallocated elsewhere on the 85 acre scheme.

 

Max James, Director of Quintain, commented:

 

"The disposal of the Plaza Hotel represents the continuation of our strategy of releasing capital from assets where value has been added while creating a vibrant entertainment destination at Wembley. Sojourn is a recognised long term hotel investor and joins Keystone, Barclaycard, Cineworld and PowerLeague as valued partners participating in and benefiting from the regeneration of Wembley.

 

"The transaction brings the quantum of capital now released from Wembley to £70 million in this financial year, demonstrating further progress against the milestone target of £100m and contributing to the reduction of forecast gearing levels."

 

Shiraz Boghani, Chairman of Sojourn Hotels, added:

 

"This acquisition fits with our investment strategy of acquiring assets that provide the opportunity for growth. Quintain's regeneration of Wembley is gathering pace. With the Olympics next year and subsequent opening of the London Designer Outlet at the heart of the scheme in 2013, we believe that we will soon see Wembley transformed into a thriving and dynamic quarter of London."

 

The Plaza Hotel provides 306 bedrooms and suites, meeting rooms and a gym. The new Hilton will offer 361 bedrooms and suites, a ballroom, skybar, conferencing facilities and a health and fitness suite, as well as views over the Stadium, Arena and London Designer Outlet.

 

For further information, please contact:

 

Quintain Estates and Development plc

Max James / Cressida Curtis

Tel: +44 (0) 20 7495 8968

 

FTI Consulting

Dido Laurimore / Toyah Simpson

Tel: +44 (0) 20 7831 3113

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISLLFSALALRLIL
Date   Source Headline
15th Apr 20267:00 amRNSDirectorate change
23rd Mar 20267:00 amRNSInterim Results & Notice of Investor Presentation
19th Mar 20267:00 amRNSAppointment of Non-Executive Director
3rd Feb 20267:00 amRNS-RPublication of 2025 Sustainability Report
12th Jan 20267:00 amRNSExtension of Exclusive Agreement with Nouryon
9th Jan 20267:00 amRNSDirector/PDMR Shareholding and Directorate Change
4th Dec 202512:17 pmRNSDirector/PDMR Shareholding
28th Nov 20252:55 pmRNSResult of AGM
28th Nov 20257:00 amRNSAGM Statement
7th Nov 20253:01 pmRNSDirector/PDMR Shareholding
6th Nov 20251:46 pmRNSDirector/PDMR Shareholding
28th Oct 20255:23 pmRNSPosting of Annual Report and Notice of AGM
27th Oct 20257:00 amRNSIssue of Options and Director Dealing
13th Oct 20257:00 amRNSIssue of Share Options and Director/PDMR Dealing
29th Sep 20257:00 amRNSFinal Results and Notice of AGM
26th Sep 20257:00 amRNSValkor update
17th Sep 20257:00 amRNSSuccessful Sparkle Power Programme Testing
15th Sep 20257:00 amRNSCEO Appointment
18th Aug 20257:00 amRNSBusiness Update
25th Jul 20257:00 amRNSDirector / PDMR Shareholding
14th Jul 20258:00 amRNSDirector/PDMR Shareholding
4th Jul 202511:50 amRNSExercise of Options and Total Voting Rights
17th Jun 20257:00 amRNSJoint Development Agreement with Alder Energy LLC
10th Jun 20257:00 amRNSBusiness Update
23rd May 20257:00 amRNSExercise of Warrants
1st May 20257:01 amRNSTotal Voting Rights
1st May 20257:00 amRNSManagement Update
3rd Apr 20257:00 amRNSExercise of Share Options
1st Apr 20257:00 amRNSMAC2 Services Agreement
26th Mar 202512:46 pmRNSDirector/PDMR Shareholding
26th Mar 20257:00 amRNSLicella Joint Development Agreement
24th Mar 20257:00 amRNSInterim Results and Investor Presentation
13th Mar 20257:00 amRNS-RAppointment of Head of Marine
31st Jan 20257:00 amRNSResult of Retail Offer
30th Jan 20252:36 pmRNSIncrease of Retail Offer
28th Jan 20257:00 amRNSAppointment of Director
24th Jan 202510:04 amRNSRetail Offer - Notice of IMC Presentation
24th Jan 20257:05 amRNSRetail Offer
24th Jan 20257:00 amRNSResult of Placing and Subscription
23rd Jan 20254:51 pmRNSProposed Placing, Subscription and Retail Offer
15th Jan 20257:00 amRNSValkor License Revenues
16th Dec 20247:00 amRNSMaterial Transfer Agreement with Sparkle Power SA
5th Dec 20247:00 amRNS-RbioMSAR™ Development Update
26th Nov 20247:00 amRNSProject Agreement with MSC and Cargill
25th Nov 20247:00 amRNSCollaboration Agreement with Auramarine
22nd Nov 20244:57 pmRNSResult of AGM
22nd Nov 20247:00 amRNSAGM Statement
25th Oct 20244:05 pmRNSPosting of Annual Report & Notice of AGM
30th Sep 20247:00 amRNSFinal Results and Notice of AGM
2nd Aug 20247:00 amRNSIssue of Share Options and Director/PDMR Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.